Astec LifeSciences Limited — Others, 30-05-2025: Change in Director(s)

Astec LifeSciences has announced a board meeting where shareholders approved Burjis Nadir Godrej as Managing Director for five years from April 2025. He will serve without remuneration, reflecting continuity from the promoter family while keeping executive pay unchanged. His appointment is fully cleared by regulatory authorities, indicating stable leadership that could shape the company’s strategic path going forward. This move reassures investors about governance and cost management at the top level.